Tolerability of postexposure prophylaxis with zidovudine, lamivudine, and nelfinavir for human immunodeficiency virus infection

Clinical Infectious Diseases

Volumn 32, Issue 10, 2001, Pages 1494-1495

  Rabaud, Christian ^a   Bevilacqua, Sibylle ^a   Beguinot, Isabelle ^a   Dorvaux, Véronique ^a   Schuhmacher, Hélène ^a   May, Thierry ^a   Canton, Philippe ^a  

^a Soins sur l Immunodéficience Humaine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; NELFINAVIR; ZIDOVUDINE;

ADULT; ARTICLE; DISEASE TRANSMISSION; DRUG EXPOSURE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FRANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROPHYLAXIS; SEROLOGY; SIDE EFFECT;

ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HUMANS; LAMIVUDINE; NELFINAVIR; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; ZIDOVUDINE;

EID: 0035873209     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/320166     Document Type: Article

References (6)

1. Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy
2. Principales dispositions de la circulaire DGS/DH/DRT/DSS no. 98/228 du 09/04/1998
3. Transmission of antiretroviral-drug-resistant HIV-1 variants
4. Tolerability and side-effects of post-exposure prophylaxis for HIV infection
5. Post-exposure prophylaxis for HIV infection
6. Tolerance, compliance and psychological consequences of post-exposure prophylaxis in health-care workers